Deals

Iron supplements specialist PharmaNutra has penned distribution deals to take its products to additional markets across the Americas and the Middle East & North Africa.

Azelis adds dietary supplement ingredients and a large customer base across Spain to its portfolio with the acquisition of Solchem Nature.

Wellnex bringing brands such as Pain Away, Wakey Wakey and Nighty Night to UK market shortly after gaining admission to the the AIM market of the London Stock Exchange.

Consumer health player Karo is changing hands from EQT to KKR in a deal thought to value the Stockholm-based firm at over €2.5bn.

Eleat's acquisition encompasses Clasado's Bimuno finished supplement product line and customer base, but not its Bimuno GOS proprietary galactooligosaccharide prebiotic ingredient.

By taking a majority stake in dynamic dietary supplements firm Braineffect, Germany's Schwabe can reach a new, younger target audience for its OTC herbal medicines.

Direct seller has deals to fully acquire and 51% ownership of Link BioSciences, which formulates personalized supplements. It also announced a deal to acquire Pruvit Ventures, ketone supplements direct seller.

Australia's SFI Health looking to take Equazen omega-3 fatty acids supplement to new markets to capitalize on Europe's fast-growing brain health segment.

A journey began eight years ago continues for Doc Generici – now rebranded as DOC Pharma – as it continues to diversify its offerings beyond conventional generic prescription pharmaceuticals.

UK firm links up with ingredients giant Kemin to offer probiotics for cardiometabolic health.

Cooper takes another step in its international expansion strategy through a partnership with Romania’s MagnaPharm for the distribution and commercialization of its self-care brand portfolio in Central and Eastern Europe (CEE).

With the acquisition of HKS Health Solutions, 1Q Health Group states its ambition to be the leading full-service CDMO in Europe. Separately, Italy's Ourvita enhances its capabilities through a deal for Poland's Laboratoria Natury.

Now backed by private-equity firm 21 Invest, Omega Pharma is bolstering its Italian nutraceutical portfolio through the acquistion of Inpha and its Normocis brand.

Deal for fellow Belgian firm Kela will bolster Ceres' consumer health offering in Europe with brands such as Folavit and Hyalo.

Helen of Troy Ltd. is acquiring Olive & June DIY manicure/pedicure brand for $240m, a price that implies a multiple of less than 11x estimated calendar year 2025 adjusted EBITDA. Separately, Guthy-Renker LLC and celebrity Paris Hilton partner to launch 11:11 Beauty; Beauty Biz Roundup

Focusing on the transitional elements of hormone health, marketing dietary supplements to women going through perimenopause and menopause, Health & Her has been acquired by UK-based Venture Life.

Beachbody offers supplement sales using health savings accounts; PlantX, Boka launches oral health supplements; supplements take Form from RTE meal provider Factor; LIV3 JV behind marketing SugarShield; Ghost among Keurig Dr Pepper brands; and Nutra-Med Packaging expands with Legacy Pharma.

Cork-based iron supplement manufacturer Solvotrin teams up with app developer Clue to offer consumers a free year's subscription to the latter's menstrual health app.

Bodybuilding.com reintroduces itself as ‘BBCOM’ with new plans; Flashlight Capital bids to buy Korea tobacco giant’s ginseng business; Hello Cake acquires Trigg Laboratories to be vertically integrated; Actylis expands into supplements, OTCs with Pharm-Rx; Helaina adds $45M funding, launches ingredient sales; ophthalmic drug firm Scope adds Eyevitamins supplements; 5 Star Nutrition’s franchising to expand.

Control of Sanofi Consumer Healthcare – recently rebranded as Opella – may soon pass to US private-equity firm CD&R but the French firm looks set to retain a substantial stake in a business which has some big Rx-to-OTC switches in the pipeline.